Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 517594, 7 pages
http://dx.doi.org/10.1155/2010/517594
Research Article

Proinflammatory Mediators of Toxic Shock and Their Correlation to Lethality

1Integrated Toxicology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011, USA
2Statistics Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011, USA

Received 20 October 2009; Revised 3 March 2010; Accepted 22 March 2010

Academic Editor: Tânia Fröde

Copyright © 2010 Teresa Krakauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Proft and J. D. Fraser, “Bacterial superantigens,” Clinical and Experimental Immunology, vol. 133, no. 3, pp. 299–306, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Morrison and J. L. Ryan, “Endotoxins and disease mechanisms,” Annual Review of Medicine, vol. 38, pp. 417–438, 1987. View at Google Scholar · View at Scopus
  4. B. L. Kotzin, D. Y. M. Leung, J. Kappler, and P. Marrack, “Superantigens and their potential role in human disease,” Advances in Immunology, vol. 54, pp. 99–166, 1993. View at Google Scholar · View at Scopus
  5. J. K. McCormick, J. M. Yarwood, and P. M. Schlievert, “Toxic shock syndrome and bacterial superantigens: an update,” Annual Review of Microbiology, vol. 55, pp. 77–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Choi, B. Kotzin, L. Hernon, J. Callahan, P. Marrack, and J. Kappler, “Interaction of Staphylococcus aureus toxin “superantigens” with human T cells,” Proceedings of the National Academy of Sciences USA, vol. 86, pp. 8941–8945, 1989. View at Google Scholar
  7. D. L. Stevens, “The toxic shock syndromes,” Infectious Disease Clinics of North America, vol. 10, no. 4, pp. 727–746, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Krakauer, “Immune response to staphylococcal superantigens,” Immunologic Research, vol. 20, no. 2, pp. 163–173, 1999. View at Google Scholar · View at Scopus
  9. R. R. Ingalls, H. Heine, E. Lien, A. Yoshimura, and D. Golenbock, “Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors,” Infectious Disease Clinics of North America, vol. 13, no. 2, pp. 341–353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Ulevitch and P. S. Tobias, “Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin,” Annual Review of Immunology, vol. 13, pp. 437–456, 1995. View at Google Scholar · View at Scopus
  11. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr., “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-L. Vincent and E. Abraham, “The last 100 years of sepsis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 3, pp. 256–263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Madsen, “Toxins as weapons of mass destruction: a comparison and contrast with biological-warfare and chemical-warfare agents,” Clinics in Laboratory Medicine, vol. 21, no. 3, pp. 593–605, 2001. View at Google Scholar · View at Scopus
  14. J. A. Mollick, M. Chintagumpala, R. G. Cook, and R. Rich, “Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype,” Journal of Immunology, vol. 146, no. 2, pp. 463–468, 1991. View at Google Scholar · View at Scopus
  15. B. Fleischer, H. Schrezenmeier, and P. Conradt, “T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures,” Cellular Immunology, vol. 120, no. 1, pp. 92–101, 1989. View at Google Scholar · View at Scopus
  16. T. Miethke, C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner, “T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor,” Journal of Experimental Medicine, vol. 175, no. 1, pp. 91–98, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. Sarawar, M. A. Blackman, and P. C. Doherty, “Superantigen shock in mice with an inapparent viral infection,” Journal of Infectious Diseases, vol. 170, no. 5, pp. 1189–1194, 1994. View at Google Scholar · View at Scopus
  18. R. L. Stone and P. M. Schlievert, “Evidence for the involvement of endotoxin in toxic shock syndrome,” Journal of Infectious Diseases, vol. 155, no. 4, pp. 682–689, 1987. View at Google Scholar · View at Scopus
  19. B. G. Stiles, S. Bavari, T. Krakauer, and R. G. Ulrich, “Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release,” Infection and Immunity, vol. 61, no. 12, pp. 5333–5338, 1993. View at Google Scholar
  20. M. Nagaki, Y. Muto, H. Ohnishi et al., “Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B,” Gastroenterology, vol. 106, no. 2, pp. 450–458, 1994. View at Google Scholar · View at Scopus
  21. J. Y.-J. Chen, Y. Qiao, J. L. Komisar, W. B. Baze, I.-C. Hsu, and J. Tseng, “Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D,” Infection and Immunity, vol. 62, no. 10, pp. 4626–4631, 1994. View at Google Scholar · View at Scopus
  22. T. Krakauer and B. G. Stiles, “Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 4, pp. 594–598, 1999. View at Google Scholar · View at Scopus
  23. T. Krakauer and M. Buckley, “Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 1, pp. 391–395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. B. G. Stiles, Y. G. Campbell, R. M. Castle, and S. A. Grove, “Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1,” Infection and Immunity, vol. 67, no. 3, pp. 1521–1525, 1999. View at Google Scholar · View at Scopus
  25. D. Le Roy, F. Di Padova, R. Tees et al., “Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14,” Journal of Immunology, vol. 162, no. 12, pp. 7454–7460, 1999. View at Google Scholar · View at Scopus
  26. T. Krakauer, J. Vilcek, and J. J. Oppenheim, “TNF family cytokines, chemokines and other pro- or anti-inflammatory cytokines,” in Fundamental Immunology, W. Paul, Ed., pp. 783–819, Raven Press, New York, NY, USA, 4th edition, 1998. View at Google Scholar
  27. W. G. Glass, H. F. Rosenberg, and P. M. Murphy, “Chemokine regulation of inflammation during acute viral infection,” Current Opinion in Allergy and Clinical Immunology, vol. 3, no. 6, pp. 467–473, 2003. View at Publisher · View at Google Scholar · View at Scopus